Introduction {#sec1-0300060518765846}
============

Wolff-Parkinson-White (WPW) syndrome is a frequent cardiac manifestation of Leber's hereditary optic neuropathy (LHON).^[@bibr1-0300060518765846]^ In two series of 163 and 51 genetically-confirmed LHON patients, WPW syndrome occurred in 9% of each of them.^[@bibr1-0300060518765846],[@bibr2-0300060518765846]^ WPW syndrome was also reported in a further patient with left ventricular hypertrabeculation/noncompaction (LVHT).^[@bibr3-0300060518765846]^ This case report describes a patient with LHON, WPW syndrome and LVHT who had developed asymptomatic, nonsustained ventricular tachycardias.

Case report {#sec2-0300060518765846}
===========

The patient is a 66-year-old Caucasian male (height 186 cm; weight 98 kg) who acutely developed binocular visual disturbance at the age of 24 years. Visual acuity progressively declined within 1 month to seeing only contours. Upon ophthalmological work-up, LHON was suspected. Visual acuity slightly improved over the following years. The diagnosis was genetically confirmed by detection of the primary LHON mutation m.3460G\>A at the age of 49 years. At the age of 60 years, he underwent right hip replacement therapy. At the age of 61 years, he experienced a speech disturbance for 4 days, which was attributed to an ischaemic stroke in the right frontoparietal and occipitoparietal regions with complete remission. Carotid ultrasound at that time revealed occlusion of the right carotid artery. A mild stenosis was diagnosed on the left carotid artery. Cardiovascular risk factors included arterial hypertension and hyperlipidaemia. Since the age of 65 years, he has experienced recurrent nonsystematic vertigo. He had a previous history of smoking 5 pack/years until the age of 61 years. His history was further positive for recurrent, sometimes traumatic falls. The family history was positive for LHON in his brother, the oldest sister of his mother, the second sister of his mother, and one female cousin. The mutation of the index case was also found in his brother and one aunt. The brother with LHON had LVHT, a complex-I defect on biochemical investigations of the muscle homogenate, was an alcoholic, had died suddenly, and had been previously described.^[@bibr3-0300060518765846],[@bibr4-0300060518765846]^ The index patient's mother had died from a 'valve abnormality'. His brother had WPW syndrome as well.

At the age of 66 years, he was able to read letters with a height of approximately 4 cm and was able to watch television on an oversized screen. He was in a depressive mood since the death of his partner 5 years earlier and the sudden, unexplained death of his brother 1 year earlier, whom he found dead in his flat. Neurological examinations revealed markedly reduced visual acuity, positional tremor, past-pointing bilaterally, and reduced Achilles tendon reflexes (already present at age 50 years but not at age 24 years). Serum lactate, which was normal at age 24 years, was 2.5 mmol/l (normal range, 0.5--1.6 mmol/l), creatine kinase was 238 U/l (normal value, \<190 U/l), and folic acid was 2.49 ng/ml (normal range, 4.6--18.7 ng/ml). Nerve conduction studies revealed a sensory polyneuropathy of the mixed type in the lower legs. Carotid ultrasound confirmed the previously diagnosed occlusion of the right carotid artery but could not confirm stenosis of the left carotid artery, where only plaques were found.

Cardiologically, the patient had a history of poorly controlled arterial hypertension since the age of 25 years. At 50 years of age, he started suffering from palpitations. At that time, electrocardiogram (ECG) showed a delta wave indicating WPW syndrome, signs of left ventricular hypertrophy and a right bundle-branch-block (RBBB). Echocardiography revealed an increased thickness of the left ventricular walls and LVHT affecting the apex and the posterior wall. Systolic function was normal. By Doppler-sonography, diastolic dysfunction (impaired relaxation) was diagnosed. Treatment with 20 mg lercanidipine, orally, twice daily and 32 mg candesartan, orally, daily was initiated. His history was negative for syncopes, atrial fibrillation, or resuscitation. The patient refused further cardiological follow-up.

In May 2017, at the age of 66 years, the patient was admitted to the Second Medical Department with Cardiology and Intensive Care Medicine, Krankenanstalt Rudolfstiftung, Vienna, Austria because of increasing vertigo during the previous 1 year and agreed to undergo further cardiological investigations. The clinical cardiological examination was normal. Blood pressure was initially high but normal at discharge. Transthoracic echocardiography showed LVHT and myocardial thickening but normal systolic function. The ECG was unchanged showing RBBB, occasional ventricular ectopic beats, and WPW syndrome with a PQ-time of 104 ms and an intermittent delta wave. During telemetric monitoring, multiple ventricular ectopic beats and nonsustained ventricular tachycardia were observed. Echocardiographically, left ventricular wall thickening had increased and LVHT was only visible in the posterior wall ([Figure 1](#fig1-0300060518765846){ref-type="fig"}). During stress-testing, the RBBB morphology of the QRS-complex disappeared at 55 Watts and recurred during rest. Considering these findings and the family history, it was decided to perform an electrophysiological investigation because of suspected left lateral pathway of the WPW syndrome. Electrophysiological investigations revealed a 'bizarre' cardiac conduction system, which is why the cardiologists refrained from undertaking radiofrequency ablation (RFA). Instead, implantation of an implantable cardioverter defibrillator (ICD) was proposed but refused by the patient. His last medications included: 50 mg trazodone, orally, daily; 100 mg acetyl-salicylic acid orally, daily; 20 mg lercanidipine, orally, twice daily; 32 mg candesartan, orally, daily; 2 mg lorazepam, orally, daily; 4 mg doxazosin, orally, three-times daily; 10 mg escitalopram, orally, daily; 10 mg ezetimibe, orally, daily; 1 mg rilmenidine, orally, twice daily; and 5 mg folic acid, orally, daily.

![Transthoracic echocardiography showing left ventricular hypertrabeculation/noncompaction at the posterior wall in the index case.](10.1177_0300060518765846-fig1){#fig1-0300060518765846}

Discussion {#sec3-0300060518765846}
==========

The present patient with LHON is interesting because of the simultaneous occurrence of WPW syndrome with nonsustained ventricular tachycardias and LVHT. WPW syndrome has been repeatedly reported in patients with LHON and occurred with a frequency of 9% in a large Japanese cohort.^[@bibr1-0300060518765846]^ This figure was confirmed in a Finnish study of 51 genetically-confirmed LHON patients.^[@bibr2-0300060518765846]^ In this study, 30 patients carried the m.11778G\>A mutation and 10 patients the m.3460G\>A mutation.^[@bibr2-0300060518765846]^ The remaining patients carried other LHON mutations. None of these previously reported patients had undergone RFA or implantation of an ICD. LVHT was not detected in any of the previously described patients with LHON, except for the brother of the present index case.^[@bibr3-0300060518765846],[@bibr4-0300060518765846]^

In the present patient, WPW syndrome was known since the age of 50 years and had not yet manifested clinically. Nonetheless, cardiologists proposed ablation to prevent future complications, such as ventricular arrhythmias or sudden cardiac death (SCD). SCD in association with WPW syndrome has been previously described,^[@bibr5-0300060518765846]^ particularly in children.^[@bibr6-0300060518765846]^ A further reason was the nonsustained ventricular tachycardia on telemetry. A third indication for RFA in the index case was the family history. His brother who also had LHON and LVHT had died suddenly, and it was suspected that it was SCD. Whether ablation of a WPW syndrome in general is truly justified or simply an over-reaction is under debate, since the significance of WPW syndrome is also a matter of debate.^[@bibr7-0300060518765846]^ However, since the conduction system was not accessible to RFA in the present patient, cardiologists suggested ICD implantation.

Whether WPW syndrome is a complication of LVHT or a manifestation of LHON remains unknown. WPW syndrome may not only be a cardiac manifestation of primary LHON mutations but also a complication of LVHT.^[@bibr8-0300060518765846]^ WPW syndrome has been repeatedly reported in association with LVHT ([Table 1](#table1-0300060518765846){ref-type="table"}).^[@bibr8-0300060518765846][@bibr9-0300060518765846][@bibr10-0300060518765846][@bibr11-0300060518765846][@bibr12-0300060518765846][@bibr13-0300060518765846][@bibr14-0300060518765846][@bibr15-0300060518765846][@bibr16-0300060518765846][@bibr17-0300060518765846][@bibr18-0300060518765846][@bibr19-0300060518765846][@bibr20-0300060518765846][@bibr21-0300060518765846][@bibr22-0300060518765846]--[@bibr23-0300060518765846]^ It can be speculated that WPW syndrome was a manifestation of the underlying genetic defect since LVHT may be associated with the genetic defect as well.

###### 

Patients in whom left ventricular hypertrabeculation/noncompaction and Wolff-Parkinson-White syndrome have been reported.^[@bibr8-0300060518765846][@bibr9-0300060518765846][@bibr10-0300060518765846][@bibr11-0300060518765846][@bibr12-0300060518765846][@bibr13-0300060518765846][@bibr14-0300060518765846][@bibr15-0300060518765846][@bibr16-0300060518765846][@bibr17-0300060518765846][@bibr18-0300060518765846][@bibr19-0300060518765846][@bibr20-0300060518765846][@bibr21-0300060518765846]--[@bibr22-0300060518765846]^

![](10.1177_0300060518765846-table1)

  Age         Sex   Manifestations/diagnosis   Additional cardiac abnormalities   Reference
  ----------- ----- -------------------------- ---------------------------------- -----------------------------------------------------
  20 years    F     Fabry disease              None                               Alper et al. 2016^[@bibr9-0300060518765846]^
  14 years    M     None                       Ebstein\'s anomaly, BAV            Malagoli et al. 2014^[@bibr10-0300060518765846]^
  30 years    F     Mitochondrial disorder     hCMP                               García-Díaz et al. 2013^[@bibr11-0300060518765846]^
  14 years    M     None                       None                               Ho et al. 2010^[@bibr12-0300060518765846]^
  6 months    M     None                       Bradycardia                        Salerno et al. 2008^[@bibr8-0300060518765846]^
  24 years    F     Pregnant                   None                               Munehisa et al. 2007^13^
  18 years    F     None                       Fibrillation                       Fichet et al. 2007^14^
  NM          NM    NM                         None                               El-Menyar et al. 2007 ^15^
  7 years     M     NM                         SVT, FS ↓                          Celiker et al. 2005^16^
  NA          NA    NA                         NA                                 Attenhofer Jost et al. 2005^17^
  6 months    F     None                       FS ↓                               Nihei et al. 2004^18^
  9 months    F     None                       Sudden death                       Ozkutlu et al. 2002^19^
  9 years     F     None                       Tachycardia                        Ozkutlu et al. 2002^19^
  NA          NA    NA                         NA                                 Ozkutlu et al. 2002^19^
  9 months    F     None                       Sudden death, ICD                  Yasukawa et al. 2001^20^
  5.5 years   F     None                       VEB                                Hussein et al. 1999^21^
  2 months    F     None                       FS ↓, PH                           Ichida et al. 1999^22^
  2 months    F     None                       SVT                                Ichida et al. 1999^22^
  3 years     M     None                       FS ↓                               Ichida et al. 1999^22^
  4 years     M     None                       None                               Ichida et al. 1999^22^
  28 months   M     None                       FS ↓, SVT                          Yoshinaga et al. 2013 ^23^

F, female; M, male; BAV, bicuspid aortic valve; hCMP, hypertrophic cardiomyopathy; NM, not mentioned; SVT, supraventricular tachycardia; FS, fractional shortening; NA, not accessible; ICD, implantable cardioverter defibrillator; VEB, ventricular ectopic beats; PH, pulmonary hypertension.

Whether the ischaemic stroke at age 61 years was due to an embolism originating from either the intertrabecular spaces, carotid artery dissection, macroangiopathy, a rhythm abnormality, or from temporary systolic dysfunction remains speculative. Due to the unusual distribution of the lesion not being confined to a vascular territory it can be speculated that the putative ischaemic stroke was indeed a stroke-like episode, but the particular cerebral magnetic resonance image was no longer available for review. Most likely, however, atherosclerosis was the cause.

In conclusion, LHON may be associated with cardiac disease manifesting as noncompaction, myocardial thickening, reduced systolic function, enlarged atria, RBBB, WPW syndrome, and nonsustained ventricular tachycardias. Potential complications of WPW syndrome in LHON may be prevented by RFA or implantation of an ICD.
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